Cargando…

Mental health, psychotropic medication use, and menstrual cycle characteristics

PURPOSE: To examine the influence of depressive symptoms, perceived stress, and psychotropic medication use on prospectively assessed menstrual cycle regularity and length. PARTICIPANTS AND METHODS: Data were obtained from Pregnancy Study Online, a prospective cohort study of pregnancy planners from...

Descripción completa

Detalles Bibliográficos
Autores principales: Nillni, Yael I, Wesselink, Amelia K, Hatch, Elizabeth E, Mikkelsen, Ellen M, Gradus, Jaimie L, Rothman, Kenneth J, Wise, Lauren A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118267/
https://www.ncbi.nlm.nih.gov/pubmed/30214312
http://dx.doi.org/10.2147/CLEP.S152131
_version_ 1783351897812369408
author Nillni, Yael I
Wesselink, Amelia K
Hatch, Elizabeth E
Mikkelsen, Ellen M
Gradus, Jaimie L
Rothman, Kenneth J
Wise, Lauren A
author_facet Nillni, Yael I
Wesselink, Amelia K
Hatch, Elizabeth E
Mikkelsen, Ellen M
Gradus, Jaimie L
Rothman, Kenneth J
Wise, Lauren A
author_sort Nillni, Yael I
collection PubMed
description PURPOSE: To examine the influence of depressive symptoms, perceived stress, and psychotropic medication use on prospectively assessed menstrual cycle regularity and length. PARTICIPANTS AND METHODS: Data were obtained from Pregnancy Study Online, a prospective cohort study of pregnancy planners from North America. At baseline, women reported information on demographics, anthropometrics, lifestyle, and medical history, including their use of psychotropic medications. They also completed the Major Depression Inventory and the Perceived Stress Scale. Every 8 weeks for up to 12 months or until conception, women completed follow-up questionnaires to assess changes in psychotropic medication use, perceived stress, and menstrual cycle characteristics (ie, cycle regularity and length). Women who completed at least one follow-up questionnaire from 2013 to 2018 (n=3,346) were included in the primary analyses. A total of 5,439 women were included in secondary analyses utilizing baseline data only. Primary analyses estimated prevalence ratios (PR) and 95% CIs using log-binomial regression models. RESULTS: Women with severe depressive symptoms at baseline, regardless of psychotropic medication use, had an 80% greater prevalence of irregular cycles during follow-up than women with no or low depressive symptoms (PR =1.80, 95% CI =1.48–2.19). Perceived stress was also associated with the prevalence of irregular cycles during follow-up (PR =1.33, 95% CI =1.14–1.55). Psychotropic medication use was not appreciably associated with menstrual characteristics after controlling for history of diagnosed depression and/or anxiety. Depressive symptoms, perceived stress, and psychotropic medication use showed little association with menstrual cycle length. CONCLUSION: Higher levels of depressive symptoms and perceived stress were associated with irregular menstrual cycles, but not appreciably associated with menstrual cycle length. Use of psychotropic medications was not meaningfully associated with cycle regularity or length.
format Online
Article
Text
id pubmed-6118267
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61182672018-09-13 Mental health, psychotropic medication use, and menstrual cycle characteristics Nillni, Yael I Wesselink, Amelia K Hatch, Elizabeth E Mikkelsen, Ellen M Gradus, Jaimie L Rothman, Kenneth J Wise, Lauren A Clin Epidemiol Original Research PURPOSE: To examine the influence of depressive symptoms, perceived stress, and psychotropic medication use on prospectively assessed menstrual cycle regularity and length. PARTICIPANTS AND METHODS: Data were obtained from Pregnancy Study Online, a prospective cohort study of pregnancy planners from North America. At baseline, women reported information on demographics, anthropometrics, lifestyle, and medical history, including their use of psychotropic medications. They also completed the Major Depression Inventory and the Perceived Stress Scale. Every 8 weeks for up to 12 months or until conception, women completed follow-up questionnaires to assess changes in psychotropic medication use, perceived stress, and menstrual cycle characteristics (ie, cycle regularity and length). Women who completed at least one follow-up questionnaire from 2013 to 2018 (n=3,346) were included in the primary analyses. A total of 5,439 women were included in secondary analyses utilizing baseline data only. Primary analyses estimated prevalence ratios (PR) and 95% CIs using log-binomial regression models. RESULTS: Women with severe depressive symptoms at baseline, regardless of psychotropic medication use, had an 80% greater prevalence of irregular cycles during follow-up than women with no or low depressive symptoms (PR =1.80, 95% CI =1.48–2.19). Perceived stress was also associated with the prevalence of irregular cycles during follow-up (PR =1.33, 95% CI =1.14–1.55). Psychotropic medication use was not appreciably associated with menstrual characteristics after controlling for history of diagnosed depression and/or anxiety. Depressive symptoms, perceived stress, and psychotropic medication use showed little association with menstrual cycle length. CONCLUSION: Higher levels of depressive symptoms and perceived stress were associated with irregular menstrual cycles, but not appreciably associated with menstrual cycle length. Use of psychotropic medications was not meaningfully associated with cycle regularity or length. Dove Medical Press 2018-08-28 /pmc/articles/PMC6118267/ /pubmed/30214312 http://dx.doi.org/10.2147/CLEP.S152131 Text en © 2018 Nillni et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Nillni, Yael I
Wesselink, Amelia K
Hatch, Elizabeth E
Mikkelsen, Ellen M
Gradus, Jaimie L
Rothman, Kenneth J
Wise, Lauren A
Mental health, psychotropic medication use, and menstrual cycle characteristics
title Mental health, psychotropic medication use, and menstrual cycle characteristics
title_full Mental health, psychotropic medication use, and menstrual cycle characteristics
title_fullStr Mental health, psychotropic medication use, and menstrual cycle characteristics
title_full_unstemmed Mental health, psychotropic medication use, and menstrual cycle characteristics
title_short Mental health, psychotropic medication use, and menstrual cycle characteristics
title_sort mental health, psychotropic medication use, and menstrual cycle characteristics
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118267/
https://www.ncbi.nlm.nih.gov/pubmed/30214312
http://dx.doi.org/10.2147/CLEP.S152131
work_keys_str_mv AT nillniyaeli mentalhealthpsychotropicmedicationuseandmenstrualcyclecharacteristics
AT wesselinkameliak mentalhealthpsychotropicmedicationuseandmenstrualcyclecharacteristics
AT hatchelizabethe mentalhealthpsychotropicmedicationuseandmenstrualcyclecharacteristics
AT mikkelsenellenm mentalhealthpsychotropicmedicationuseandmenstrualcyclecharacteristics
AT gradusjaimiel mentalhealthpsychotropicmedicationuseandmenstrualcyclecharacteristics
AT rothmankennethj mentalhealthpsychotropicmedicationuseandmenstrualcyclecharacteristics
AT wiselaurena mentalhealthpsychotropicmedicationuseandmenstrualcyclecharacteristics